Puma Biotechnology - Stock Price History | PBYI

Historical daily share price chart and data for Puma Biotechnology since 2020 adjusted for splits. The latest closing stock price for Puma Biotechnology as of June 03, 2020 is 11.06.
  • The all-time high Puma Biotechnology stock closing price was 275.07 on September 18, 2014.
  • The Puma Biotechnology 52-week high stock price is 15.00, which is 35.6% above the current share price.
  • The Puma Biotechnology 52-week low stock price is 5.50, which is 50.3% below the current share price.
  • The average Puma Biotechnology stock price for the last 52 weeks is 9.98.
Puma Biotechnology Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 17.9948 21.6800 42.3700 6.5000 8.7500 -57.00%
2018 52.6096 92.6500 99.2500 20.0700 20.3500 -79.41%
2017 74.4849 31.5000 132.4500 29.0000 98.8500 221.99%
2016 42.5287 73.5400 73.5400 21.8700 30.7000 -60.84%
2015 140.9730 189.8600 249.7100 64.9700 78.4000 -58.58%
2014 154.7279 102.0600 275.0700 54.9900 189.2700 82.82%
2013 43.5442 19.0100 110.1000 18.9500 103.5300 452.16%
2012 15.1608 14.0000 22.6000 11.0000 18.7500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.443B $0.272B
Puma Biotechnology, Inc. is a biopharmaceutical company focused on the acquisition, in-licensing, development and commercialization of novel therapeutics for the treatment of cancer. Its products under development include PB272 (oral neratinib) for the treatment of patients with human epidermal growth factor receptor type 2 (HER2) positive metastatic breast cancer and gastric cancer and PB272 (neratinib intravenous) for the treatment of patients with advanced cancer. Puma Biotechnology, Inc. is headquartered in Los Angeles, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.603B 14.49
Gilead Sciences (GILD) United States $91.895B 11.91
CSL (CSLLY) Australia $89.448B 0.00
Vertex Pharmaceuticals (VRTX) United States $73.705B 50.67
Regeneron Pharmaceuticals (REGN) United States $67.954B 26.19
Illumina (ILMN) United States $53.809B 55.29
Biogen (BIIB) United States $49.423B 8.46
Seattle Genetics (SGEN) United States $27.838B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.678B 11.03
Moderna (MRNA) United States $22.225B 0.00
Incyte (INCY) United States $21.933B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.519B 0.00
BioMarin Pharmaceutical (BMRN) United States $19.590B 177.59
Genmab (GMAB) Denmark $19.447B 16.02
Genmab (GNMSF) Denmark $18.331B 54.42
Alnylam Pharmaceuticals (ALNY) United States $15.939B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
BeiGene (BGNE) Cayman Islands $13.019B 0.00
Exact Sciences (EXAS) United States $12.913B 0.00
Galapagos (GLPG) Belgium $12.822B 37.97
BioNTech SE (BNTX) Germany $11.852B 0.00
Sarepta Therapeutics (SRPT) United States $11.776B 0.00
Bio-Techne Corp (TECH) United States $10.085B 66.63
QIAGEN (QGEN) Netherlands $10.007B 29.10
ARGENX SE-ADR (ARGX) Netherlands $9.958B 0.00
Horizon Therapeutics Public (HZNP) Ireland $9.606B 23.64
Guardant Health (GH) United States $8.264B 0.00
Immunomedics (IMMU) United States $7.717B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.484B 0.00
Exelixis (EXEL) United States $7.443B 26.10
Ascendis Pharma (ASND) Denmark $7.006B 0.00
Repligen (RGEN) United States $6.976B 122.36
Acceleron Pharma (XLRN) United States $5.215B 0.00
Adaptive Biotechnologies (ADPT) United States $4.926B 0.00
MyoKardia (MYOK) United States $4.854B 0.00
Emergent Biosolutions (EBS) United States $4.682B 30.69
Reata Pharmaceuticals (RETA) United States $4.664B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.479B 0.00
Zai Lab (ZLAB) China $4.416B 0.00
Mirati Therapeutics (MRTX) United States $4.386B 0.00
Vir Biotechnology (VIR) United States $4.366B 0.00
China Biologic Products (CBPO) China $4.330B 24.07
MorphoSys AG (MOR) Germany $4.284B 33.22
Global Blood Therapeutics (GBT) United States $4.193B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.171B 91.15
Blueprint Medicines (BPMC) United States $3.832B 0.00
Bluebird Bio (BLUE) United States $3.625B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.609B 0.00
Arena Pharmaceuticals (ARNA) United States $3.434B 0.00
Amicus Therapeutics (FOLD) United States $3.386B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.314B 0.00
Halozyme Therapeutics (HALO) United States $3.296B 0.00
Denali Therapeutics (DNLI) United States $3.001B 0.00
UniQure (QURE) Netherlands $2.919B 0.00
Novavax (NVAX) United States $2.877B 0.00
NeoGenomics (NEO) United States $2.766B 202.00
Insmed (INSM) United States $2.689B 0.00
Viela Bio (VIE) United States $2.660B 0.00
Alkermes (ALKS) Ireland $2.653B 52.22
Amarin (AMRN) Ireland $2.633B 0.00
Alector (ALEC) United States $2.600B 0.00
Fate Therapeutics (FATE) United States $2.484B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.483B 0.00
Inovio Pharmaceuticals (INO) United States $2.267B 0.00
Principia Biopharma (PRNB) United States $2.109B 0.00
Eidos Therapeutics (EIDX) United States $1.900B 0.00
Ligand Pharmaceuticals (LGND) United States $1.778B 69.23
Zymeworks (ZYME) Canada $1.770B 0.00
Epizyme (EPZM) United States $1.765B 0.00
Adverum Biotechnologies (ADVM) United States $1.696B 0.00
Sangamo Therapeutics (SGMO) United States $1.662B 0.00
Twist Bioscience (TWST) United States $1.595B 0.00
Arcus Biosciences (RCUS) United States $1.590B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.574B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.571B 0.00
Editas Medicine (EDIT) United States $1.552B 0.00
Akcea Therapeutics (AKCA) United States $1.525B 0.00
Mesoblast (MESO) Australia $1.524B 0.00
PHARMA MAR SA (PHMMF) Spain $1.514B 0.00
Beam Therapeutics (BEAM) United States $1.444B 0.00
Intra-Cellular Therapies (ITCI) United States $1.425B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
Zealand Pharma (ZEAL) Denmark $1.410B 0.00
REGENXBIO (RGNX) United States $1.398B 0.00
NGM Biopharmaceuticals (NGM) United States $1.388B 0.00
Coherus BioSciences (CHRS) United States $1.359B 9.49
Mersana Therapeutics (MRSN) United States $1.282B 0.00
Arvinas (ARVN) United States $1.277B 0.00
I-Mab (IMAB) China $1.260B 0.00
Cytokineticsorporated (CYTK) United States $1.255B 0.00
Revance Therapeutics (RVNC) United States $1.217B 0.00
Compugen (CGEN) Israel $1.149B 0.00
Myriad Genetics (MYGN) United States $1.147B 59.19
Intellia Therapeutics (NTLA) United States $1.041B 0.00
Sorrento Therapeutics (SRNE) United States $1.000B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.969B 0.00
Athenex (ATNX) United States $0.969B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.937B 0.00
Pharming Group (PHGUF) Netherlands $0.895B 0.00
Cue Biopharma (CUE) United States $0.874B 0.00
Heska (HSKA) United States $0.814B 0.00
Cellectis S.A (CLLS) France $0.809B 0.00
Alcobra (ARCT) United States $0.799B 0.00
NextCure (NXTC) United States $0.789B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.773B 0.00
Codexis (CDXS) United States $0.754B 0.00
Kala Pharmaceuticals (KALA) United States $0.753B 0.00
Cara Therapeutics (CARA) United States $0.742B 0.00
Kadmon Holdings (KDMN) United States $0.741B 0.00
NantKwest (NK) United States $0.738B 0.00
Retrophin (RTRX) United States $0.726B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.713B 0.00
Agenus (AGEN) United States $0.681B 0.00
Intrexon (PGEN) United States $0.676B 0.00
Vericel (VCEL) United States $0.672B 124.08
ZIOPHARM Oncology Inc (ZIOP) United States $0.669B 0.00
Castle Biosciences (CSTL) United States $0.662B 0.00
Dynavax Technologies (DVAX) United States $0.662B 0.00
Bellus Health (BLU) Canada $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 17.03
Morphic Holding (MORF) United States $0.635B 0.00
Stemline Therapeutics (STML) United States $0.627B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.622B 5.33
Athersys (ATHX) United States $0.613B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.605B 0.00
Frequency Therapeutics (FREQ) United States $0.578B 0.00
AnaptysBio (ANAB) United States $0.555B 0.00
DBV Technologies S.A (DBVT) France $0.544B 0.00
Cel-Sci (CVM) United States $0.543B 0.00
Clovis Oncology (CLVS) United States $0.537B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
MeiraGTx Holdings (MGTX) United States $0.517B 0.00
Scholar Rock Holding (SRRK) United States $0.514B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.513B 0.00
UROGEN PHARMA (URGN) United States $0.513B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.510B 0.00
VBI Vaccines (VBIV) United States $0.496B 0.00
Anika Therapeutics (ANIK) United States $0.495B 15.91
BioDelivery Sciences (BDSI) United States $0.477B 25.10
AC Immune SA (ACIU) Switzerland $0.474B 0.00
Protagonist Therapeutics (PTGX) United States $0.460B 0.00
Prothena (PRTA) Ireland $0.460B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.452B 0.00
Syros Pharmaceuticals (SYRS) United States $0.443B 0.00
Merus (MRUS) Netherlands $0.422B 0.00
Albireo Pharma (ALBO) United States $0.411B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.403B 0.00
Precision BioSciences (DTIL) United States $0.400B 0.00
MiMedx (MDXG) United States $0.398B 0.00
Seres Therapeutics (MCRB) United States $0.393B 0.00
PDL BioPharma (PDLI) United States $0.378B 324.00
CytomX Therapeutics (CTMX) United States $0.373B 0.00
ANI Pharmaceuticals (ANIP) United States $0.367B 7.26
Avid Bioservices (CDMO) United States $0.356B 0.00
Kamada (KMDA) Israel $0.337B 14.00
Selecta Biosciences (SELB) United States $0.334B 0.00
WAVE Life Sciences (WVE) Singapore $0.334B 0.00
Geron (GERN) United States $0.333B 0.00
OSMOTICA PHARM (OSMT) United States $0.325B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.315B 0.00
Verastem (VSTM) United States $0.307B 0.00
MannKind (MNKD) United States $0.307B 0.00
Menlo Therapeutics (MNLO) United States $0.304B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.292B 0.00
ChromaDex (CDXC) United States $0.291B 0.00
Liquidia Technologies (LQDA) United States $0.287B 0.00
Spero Therapeutics (SPRO) United States $0.268B 0.00
Starpharma Holdings (SPHRY) Australia $0.266B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.264B 0.00
Affimed (AFMD) Germany $0.263B 0.00
Fortress Biotech (FBIO) United States $0.261B 0.00
Cellular Biomedicine (CBMG) United States $0.256B 0.00
Abeona Therapeutics (ABEO) United States $0.256B 0.00
Pfenex (PFNX) United States $0.255B 0.00
HOOKIPA Pharma (HOOK) United States $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.250B 0.00
XOMA (XOMA) United States $0.249B 0.00
Prometic Life Sciences (LMNL) Canada $0.246B 0.00
Exicure (XCUR) United States $0.238B 0.00
Sutro Biopharma (STRO) United States $0.235B 0.00
Gritstone Oncology (GRTS) United States $0.234B 0.00
Northwest Biotherapeutics (NWBO) United States $0.224B 0.00
POXEL SA FRANCE (PXXLF) France $0.219B 0.00
IVERIC Bio (ISEE) United States $0.211B 0.00
Aduro Biotech (ADRO) United States $0.208B 0.00
ARAVIVE, INC (ARAV) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 3.08
GENFIT S.A (GNFT) France $0.199B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.198B 0.00
VTv Therapeutics (VTVT) United States $0.196B 0.00
IBio (IBIO) United States $0.194B 0.00
Five Prime Therapeutics (FPRX) United States $0.193B 0.00
Pluristem Therapeutics (PSTI) Israel $0.191B 0.00
Kindred Biosciences (KIN) United States $0.189B 0.00
Aytu Bioscience (AYTU) United States $0.186B 0.00
Strongbridge Biopharma (SBBP) United States $0.185B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.181B 0.00
TELA Bio (TELA) United States $0.177B 0.00
Cerecor (CERC) United States $0.174B 0.00
Dyadic (DYAI) United States $0.169B 0.00
Orgenesis (ORGS) United States $0.169B 0.00
Aptinyx (APTX) United States $0.163B 0.00
Celyad SA (CYAD) Belgium $0.163B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
PHASEBIO PHARMA (PHAS) United States $0.153B 0.00
Cidara Therapeutics (CDTX) United States $0.151B 0.00
Trevena (TRVN) United States $0.147B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Arbutus Biopharma (ABUS) Canada $0.144B 0.00
Enzo Biochem (ENZ) United States $0.144B 0.00
Theratechnologies (THTX) Canada $0.140B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.136B 0.00
Antibe Therapeutics (ATBPF) Canada $0.132B 0.00
VolitionRX (VNRX) United States $0.131B 0.00
Applied Genetic Technologies (AGTC) United States $0.128B 0.00
Palatin Technologies (PTN) United States $0.128B 3.28
AVEO Pharmaceuticals (AVEO) United States $0.127B 0.00
CorMedix Inc (CRMD) United States $0.122B 0.00
AIT Therapeutics (XAIR) United States $0.118B 0.00
Oncobiologics (OTLK) United States $0.118B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Cyclerion Therapeutics (CYCN) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.113B 0.00
Lumos Pharma (LUMO) United States $0.113B 0.00
Protalix BioTherapeutics (PLX) Israel $0.111B 0.00
Eton Pharmaceuticals (ETON) United States $0.108B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.105B 0.00
Windtree Therapeutics (WINT) United States $0.099B 0.00
Catalyst Biosciences (CBIO) United States $0.093B 0.00
Organovo Holdings (ONVO) United States $0.091B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
SESEN BIO, INC (SESN) United States $0.085B 0.00
Clearside Biomedical (CLSD) United States $0.085B 0.00
Celsion (CLSN) United States $0.081B 0.00
Synlogic (SYBX) United States $0.081B 0.00
Emmaus Life Sciences (EMMA) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Proteostasis Therapeutics (PTI) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.070B 0.00
Happiness Biotech Group (HAPP) China $0.069B 0.00
DiaMedica Therapeutics (DMAC) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.065B 0.00
Vaccinex (VCNX) United States $0.063B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.058B 0.00
Signal Genetics (MGEN) United States $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.054B 0.00
Celldex Therapeutics (CLDX) United States $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.050B 0.00
Cocrystal Pharma (COCP) United States $0.049B 0.00
Advaxis (ADXS) United States $0.046B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.046B 0.00
Prima BioMed (IMMP) Australia $0.046B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
OvaScience (MLND) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Cesca Therapeutics (THMO) United States $0.042B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
TrovaGene (CRDF) United States $0.041B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
TOCAGEN INC (TOCA) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Stellar Biotechnologies (EDSA) Canada $0.030B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Spherix (AIKI) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Neuralstem (SNCA) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00